NASDAQ:CLDX
$46.25
(
0.92%
)
Friday, 27th Jan 2023
Celldex Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $42.41 | $48.40 | Friday, 27th Jan 2023 CLDX stock ended at $46.25. This is 0.92% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 3.46% from a day low at $45.37 to a day high of $46.94. |
| 90 days | $32.23 | $48.40 | |
| 52 weeks | $19.85 | $48.40 |
Historical Celldex Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $45.71 | $46.94 | $45.37 | $46.25 | 225 493 |
| 2023-01-26 | $46.67 | $46.84 | $45.34 | $45.83 | 239 009 |
| 2023-01-25 | $46.35 | $46.80 | $44.91 | $46.50 | 326 307 |
| 2023-01-24 | $46.39 | $47.59 | $46.08 | $46.52 | 516 399 |
| 2023-01-23 | $46.62 | $47.17 | $45.79 | $46.59 | 327 927 |
| 2023-01-20 | $47.23 | $47.35 | $46.00 | $46.61 | 362 000 |
| 2023-01-19 | $46.39 | $47.50 | $46.25 | $46.46 | 282 141 |
| 2023-01-18 | $47.31 | $48.40 | $46.62 | $46.67 | 470 100 |
| 2023-01-17 | $45.75 | $47.02 | $45.14 | $46.94 | 320 300 |
| 2023-01-13 | $47.00 | $48.00 | $45.42 | $46.02 | 388 814 |
| 2023-01-12 | $46.58 | $48.05 | $46.16 | $47.43 | 390 900 |
| 2023-01-11 | $46.54 | $46.91 | $45.29 | $46.43 | 569 231 |
| 2023-01-10 | $44.63 | $46.94 | $44.41 | $46.68 | 363 438 |
| 2023-01-09 | $44.24 | $45.55 | $43.26 | $44.85 | 643 647 |
| 2023-01-06 | $42.97 | $43.88 | $42.41 | $43.84 | 430 100 |
| 2023-01-05 | $43.84 | $43.84 | $42.72 | $42.77 | 285 577 |
| 2023-01-04 | $43.61 | $44.61 | $43.46 | $44.22 | 404 442 |
| 2023-01-03 | $44.86 | $45.60 | $42.73 | $43.39 | 483 801 |
| 2022-12-30 | $44.70 | $45.10 | $43.81 | $44.57 | 447 242 |
| 2022-12-29 | $43.48 | $46.04 | $43.12 | $45.04 | 404 165 |
| 2022-12-28 | $43.49 | $44.22 | $43.14 | $43.19 | 287 870 |
| 2022-12-27 | $44.09 | $45.38 | $43.51 | $43.53 | 277 195 |
| 2022-12-23 | $45.39 | $45.40 | $43.51 | $44.11 | 234 514 |
| 2022-12-22 | $44.07 | $45.65 | $43.57 | $45.38 | 400 833 |
| 2022-12-21 | $41.99 | $44.56 | $41.51 | $44.42 | 574 905 |
| 2022-12-20 | $41.19 | $42.34 | $41.16 | $41.88 | 553 330 |
| 2022-12-19 | $43.52 | $43.72 | $41.17 | $41.58 | 469 351 |
| 2022-12-16 | $43.31 | $44.29 | $42.32 | $43.52 | 2 777 678 |
| 2022-12-15 | $40.29 | $44.92 | $40.16 | $44.29 | 1 404 316 |
| 2022-12-14 | $39.27 | $40.90 | $38.68 | $40.25 | 589 661 |
| 2022-12-13 | $40.00 | $40.03 | $37.60 | $39.37 | 594 596 |
| 2022-12-12 | $36.94 | $39.99 | $36.71 | $38.77 | 728 961 |
| 2022-12-09 | $38.64 | $38.72 | $37.08 | $37.15 | 398 827 |
| 2022-12-08 | $37.31 | $39.55 | $36.74 | $38.81 | 524 695 |
| 2022-12-07 | $36.37 | $37.45 | $35.66 | $37.10 | 376 665 |
| 2022-12-06 | $36.54 | $37.77 | $35.50 | $36.34 | 741 228 |
| 2022-12-05 | $37.02 | $37.37 | $35.78 | $36.66 | 604 635 |
| 2022-12-02 | $36.25 | $37.51 | $35.85 | $37.34 | 531 183 |
| 2022-12-01 | $36.92 | $37.70 | $35.98 | $36.66 | 481 367 |
| 2022-11-30 | $34.58 | $37.23 | $34.56 | $37.09 | 807 314 |
| 2022-11-29 | $33.31 | $34.27 | $32.91 | $34.26 | 355 646 |
| 2022-11-28 | $33.33 | $33.85 | $32.77 | $33.12 | 405 740 |
| 2022-11-25 | $34.17 | $34.58 | $33.51 | $33.64 | 83 493 |
| 2022-11-23 | $34.70 | $35.01 | $33.63 | $34.39 | 252 928 |
| 2022-11-22 | $33.97 | $34.63 | $33.15 | $34.56 | 264 518 |
| 2022-11-21 | $34.70 | $35.22 | $33.58 | $33.87 | 126 696 |
| 2022-11-18 | $35.09 | $35.40 | $34.24 | $34.76 | 165 177 |
| 2022-11-17 | $34.04 | $34.04 | $33.21 | $33.52 | 178 179 |
| 2022-11-16 | $36.46 | $36.81 | $34.17 | $34.22 | 180 301 |
| 2022-11-15 | $37.40 | $37.67 | $36.05 | $36.94 | 162 217 |
About Celldex Therapeutics
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
